| |
| |
|
| Insider
Information: |
Bjerkholt Eric |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
534,968 |
|
|
Indirect Shares
|
83,827 |
|
|
| Direct
Value |
$620,429 |
|
|
|
Indirect Value
|
$67,648 |
|
|
| Total
Shares |
618,795 |
|
|
| Total
Value |
$688,078 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
4
|
|
Stock
price went up :
|
6
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
6.0
|
4.0
|
| Percentage
Gain/Loss : |
 48.0%
|
276.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
EVP, CFO & Corp. Secre... |
2016-02-29 |
100,922 |
2016-02-29 |
83,827 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
273,759 |
2010-03-01 |
0 |
Premium* |
|
|
Corium International, Inc. |
CORI |
Director |
2016-05-18 |
0 |
2018-11-27 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Chief Financial Officer |
2020-10-13 |
0 |
2017-05-12 |
0 |
Premium* |
|
|
Cerus Corp |
CERS |
Director |
2023-12-13 |
142,133 |
2019-10-04 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2023-08-11 |
0 |
|
0 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
Director |
2023-05-31 |
3,684 |
2023-03-23 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-05-10 |
14,470 |
2023-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-05-12 |
4 |
B |
$19.84 |
$99,210 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-02-26 |
4 |
B |
$32.00 |
$100,000 |
D/D |
3,125 |
8,125 |
2.74 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
17,500 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-06-13 |
4 |
B |
$30.41 |
$48,663 |
D/D |
1,600 |
19,485 |
2.74 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,125 |
32,857 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-09-18 |
4 |
B |
$22.57 |
$34,977 |
D/D |
1,550 |
33,574 |
2.74 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
42,949 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
D |
$23.81 |
$47,191 |
D/D |
(1,982) |
40,967 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-03-09 |
4 |
B |
$18.97 |
$18,970 |
D/D |
1,000 |
41,967 |
2.74 |
% |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-03-12 |
4 |
B |
$15.10 |
$15,100 |
D/D |
1,000 |
42,967 |
2.74 |
% |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
45,387 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-09-15 |
4 |
D |
$34.25 |
$28,770 |
D/D |
(840) |
44,547 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-10-05 |
4 |
OE |
$19.44 |
$101,088 |
D/D |
5,200 |
49,841 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-10-10 |
4 |
D |
$34.50 |
$959,273 |
D/D |
(27,805) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-10-13 |
4 |
D |
$34.50 |
$824,723 |
D/D |
(23,905) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,414 |
26,414 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
D |
$16.02 |
$92,097 |
D/D |
(5,750) |
20,664 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,434 |
23,098 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-02-11 |
4 |
S |
$12.74 |
$11,403 |
D/D |
(895) |
22,203 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,414 |
38,617 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
S |
$22.29 |
$128,602 |
D/D |
(5,770) |
32,847 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
S |
$24.68 |
$71,357 |
D/D |
(2,891) |
37,289 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
40,180 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,435 |
39,724 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-10 |
4 |
S |
$23.75 |
$20,352 |
D/D |
(857) |
38,867 |
0 |
% |
|
82 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
